JUSTIN WILSON: Open Payments
NPI 1417420704 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 84 payments from 21 companies in 2025. Trend: 2023 $852 · 2024 $4,190 · 2025 $1,658
Food & beverage: $1,658
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $283 |
| PFIZER INC. | 12 | $247 |
| GlaxoSmithKline, LLC. | 7 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $138 |
| Lilly USA, LLC | 7 | $123 |
| Novo Nordisk Inc | 4 | $98 |
| Amgen Inc. | 5 | $95 |
| ABBVIE INC. | 4 | $80 |
| Exact Sciences Corporation | 3 | $65 |
| Dexcom, Inc. | 3 | $57 |
Products named: ELIQUIS, Kerendia, BREZTRI, TRELEGY ELLIPTA, FARXIGA, REXULTI, Ozempic, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
